CN1176667C - 一种治疗胃、肠疾病的药物及其制法 - Google Patents
一种治疗胃、肠疾病的药物及其制法 Download PDFInfo
- Publication number
- CN1176667C CN1176667C CNB011434546A CN01143454A CN1176667C CN 1176667 C CN1176667 C CN 1176667C CN B011434546 A CNB011434546 A CN B011434546A CN 01143454 A CN01143454 A CN 01143454A CN 1176667 C CN1176667 C CN 1176667C
- Authority
- CN
- China
- Prior art keywords
- medicine
- full
- parch
- parts
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 89
- 208000028774 intestinal disease Diseases 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims abstract description 16
- 230000008569 process Effects 0.000 title claims description 8
- 208000037902 enteropathy Diseases 0.000 title abstract description 4
- 229940079593 drug Drugs 0.000 title description 14
- 239000000843 powder Substances 0.000 claims abstract description 42
- 241000283973 Oryctolagus cuniculus Species 0.000 claims abstract description 11
- 241000283074 Equus asinus Species 0.000 claims abstract description 10
- 241001465754 Metazoa Species 0.000 claims abstract description 9
- 210000002784 stomach Anatomy 0.000 claims description 38
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 239000002552 dosage form Substances 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 241000283898 Ovis Species 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 208000007882 Gastritis Diseases 0.000 abstract description 36
- 230000000694 effects Effects 0.000 abstract description 16
- 230000001684 chronic effect Effects 0.000 abstract description 12
- 230000002183 duodenal effect Effects 0.000 abstract description 9
- 208000000718 duodenal ulcer Diseases 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 208000007107 Stomach Ulcer Diseases 0.000 abstract description 6
- 230000004054 inflammatory process Effects 0.000 abstract description 6
- 206010054949 Metaplasia Diseases 0.000 abstract description 5
- 208000012287 Prolapse Diseases 0.000 abstract description 5
- 208000016644 chronic atrophic gastritis Diseases 0.000 abstract description 5
- 208000021735 chronic enteritis Diseases 0.000 abstract description 5
- 210000001156 gastric mucosa Anatomy 0.000 abstract description 5
- 208000004300 Atrophic Gastritis Diseases 0.000 abstract description 4
- 208000036495 Gastritis atrophic Diseases 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 241001494479 Pecora Species 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 206010020718 hyperplasia Diseases 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 8
- 229910052799 carbon Inorganic materials 0.000 abstract 6
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000002390 hyperplastic effect Effects 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 18
- 208000010643 digestive system disease Diseases 0.000 description 18
- 208000018685 gastrointestinal system disease Diseases 0.000 description 18
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 238000003745 diagnosis Methods 0.000 description 11
- 230000000968 intestinal effect Effects 0.000 description 9
- 206010003694 Atrophy Diseases 0.000 description 8
- 230000037444 atrophy Effects 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 230000002496 gastric effect Effects 0.000 description 7
- 238000002575 gastroscopy Methods 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 206010020565 Hyperaemia Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010020880 Hypertrophy Diseases 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 210000004877 mucosa Anatomy 0.000 description 5
- 210000004203 pyloric antrum Anatomy 0.000 description 5
- 241000590002 Helicobacter pylori Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 206010009887 colitis Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 201000005917 gastric ulcer Diseases 0.000 description 4
- 230000015689 metaplastic ossification Effects 0.000 description 4
- 229940023488 pill Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 210000004913 chyme Anatomy 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000019621 digestibility Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229940037467 helicobacter pylori Drugs 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- KZFDVWZZYOPBQZ-UHFFFAOYSA-K bismuth;potassium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].[Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KZFDVWZZYOPBQZ-UHFFFAOYSA-K 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 208000011906 peptic ulcer disease Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010017865 Gastritis erosive Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010064147 Gastrointestinal inflammation Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010061297 Mucosal erosion Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000589973 Spirochaeta Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000004083 gastrointestinal agent Substances 0.000 description 1
- 229940127227 gastrointestinal drug Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
病名疗及程例及数疗效 | 胃溃疡 | 十二指肠溃疡 | 慢性浅表性胃炎 | 胃窦炎 | 胃局部及大面积萎缩性胃炎 | 增生型胃炎 | 萎缩性胃窦炎 | 萎缩性伴肠上皮生胃炎 | 胃粘膜脱垂 | 慢性肠炎及结肠炎 |
265 | 140 | 138 | 67 | 184 | 36 | 61 | 34 | 22 | 161 | |
疗程 | 2-3 | 2-3 | 2-3 | 4 | 4-5 | 4-5 | 4 | 5 | 4 | 2-3 |
治愈 | 262 | 138 | 132 | 62 | 175 | 31 | 59 | 28 | 20 | 157 |
有效 | 264 | 140 | 138 | 64 | 180 | 34 | 60 | 33 | 22 | 161 |
无效 | 1 | 3 | 4 | 2 | 1 | 1 | ||||
总有效率 | 99.6% | 100% | 100% | 97.3% | 97.8% | 94.4% | 98.3% | 97% | 100% | 100% |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011434546A CN1176667C (zh) | 2001-12-28 | 2001-12-28 | 一种治疗胃、肠疾病的药物及其制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011434546A CN1176667C (zh) | 2001-12-28 | 2001-12-28 | 一种治疗胃、肠疾病的药物及其制法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1359685A CN1359685A (zh) | 2002-07-24 |
CN1176667C true CN1176667C (zh) | 2004-11-24 |
Family
ID=4677173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011434546A Expired - Fee Related CN1176667C (zh) | 2001-12-28 | 2001-12-28 | 一种治疗胃、肠疾病的药物及其制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1176667C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105832952A (zh) * | 2016-05-16 | 2016-08-10 | 史家举 | 一种治疗肝气郁结型胃黏膜脱垂症的中药组合物 |
-
2001
- 2001-12-28 CN CNB011434546A patent/CN1176667C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1359685A (zh) | 2002-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1072952C (zh) | 用于治疗慢性咽炎的中药丸剂 | |
CN117379521A (zh) | 一种治疗幽门螺杆菌的植物细胞酶解提取物的制备方法及其应用 | |
CN101564458A (zh) | 一种中药组合物在制备治疗支气管炎药物中的应用 | |
CN1943754A (zh) | 一种治疗胃肠疾病的药物 | |
CN100342903C (zh) | 一种治疗胃肠疾病的中药组合物 | |
CN1176667C (zh) | 一种治疗胃、肠疾病的药物及其制法 | |
CN1150927C (zh) | 一种治疗急慢性咽喉炎,扁桃体炎的药物及其生产方法 | |
CN109966442B (zh) | 一种治疗溃疡性结肠炎的内服外用中药组合物及其制备方法 | |
CN103816421A (zh) | 一种治疗反流性食管炎的中药制剂及制备方法 | |
CN114796283A (zh) | 五谷虫提取物用于制备治疗消化性疾病药物中的应用及药物组合物 | |
CN1053818C (zh) | 溃疡散 | |
CN1294919C (zh) | 治疗痔疮的外敷药袋及制作方法 | |
CN1943746A (zh) | 一种治疗荨麻疹的中药制剂 | |
CN108939011A (zh) | 一种治疗癌症的中草药配方 | |
CN1088378C (zh) | 治疗慢性浅表性胃炎的中药口服液及其制备方法 | |
CN101284020B (zh) | 一种治疗狂犬病的中药口服制剂 | |
CN1248697C (zh) | 一种治疗慢性肠炎的药物组合物及其制备方法 | |
CN105232991A (zh) | 一种治疗胃黏膜损伤的药物组合物 | |
CN1301741C (zh) | 一种治疗瘀阻糜烂溃疡久泻的中药胶囊丸 | |
CN1058407C (zh) | 一种治疗胃病的药物 | |
CN1408405A (zh) | 含有山嵛菜的药物或保健品 | |
CN102423319B (zh) | 治疗口腔溃疡的中药组合物 | |
CN117883536A (zh) | 一种用于治疗肠道炎癌转化类疾病的中药组合物及其应用 | |
CN102205085B (zh) | 一种治疗胃病的溃疡散 | |
CN1751596A (zh) | 提高抗消化道感染免疫的中药保健食品及软胶囊和制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: XU GUIFU Free format text: FORMER OWNER: WANG JIABIN Effective date: 20060519 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20060519 Address after: 116600, 2-3-3, building 46, Kong Sheng District, West Port District, Dalian Development Zone, Liaoning Patentee after: Xu Guifu Address before: 116600, No. 3, building 2, building 46, building 3, Kong Sheng building, West Port District, Dalian Development Zone, Liaoning, China Patentee before: Wang Jiabin |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |